"Vaccination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis.
Descriptor ID |
D014611
|
MeSH Number(s) |
E02.095.465.425.400.530.890 E05.478.550.600.890 N02.421.726.758.310.890 N06.850.780.200.425.900 N06.850.780.680.310.890
|
Concept/Terms |
Immunization, Active- Immunization, Active
- Active Immunization
- Active Immunizations
- Immunizations, Active
|
Below are MeSH descriptors whose meaning is more general than "Vaccination".
Below are MeSH descriptors whose meaning is more specific than "Vaccination".
This graph shows the total number of publications written about "Vaccination" by people in this website by year, and whether "Vaccination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 2 | 2 |
1996 | 3 | 6 | 9 |
1997 | 1 | 1 | 2 |
1998 | 4 | 4 | 8 |
1999 | 3 | 5 | 8 |
2000 | 6 | 6 | 12 |
2001 | 2 | 6 | 8 |
2002 | 6 | 6 | 12 |
2003 | 2 | 9 | 11 |
2004 | 1 | 10 | 11 |
2005 | 3 | 10 | 13 |
2006 | 9 | 6 | 15 |
2007 | 5 | 7 | 12 |
2008 | 3 | 3 | 6 |
2009 | 7 | 8 | 15 |
2010 | 2 | 7 | 9 |
2011 | 7 | 12 | 19 |
2012 | 7 | 10 | 17 |
2013 | 9 | 8 | 17 |
2014 | 13 | 10 | 23 |
2015 | 5 | 8 | 13 |
2016 | 22 | 10 | 32 |
2017 | 19 | 15 | 34 |
2018 | 9 | 17 | 26 |
2019 | 11 | 30 | 41 |
2020 | 13 | 23 | 36 |
2021 | 18 | 48 | 66 |
2022 | 4 | 57 | 61 |
2023 | 2 | 48 | 50 |
2024 | 9 | 42 | 51 |
2025 | 3 | 10 | 13 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vaccination" by people in Profiles.
-
A framework-based guide for adapting and implementing primary care-based pediatric interventions to the pediatric oncology setting: HPV PROTECT as an exemplar. Cancer. 2025 May 01; 131(9):e35857.
-
Influenza Vaccine Effectiveness Against Illness and Asymptomatic Infection in 2022-2023: A Prospective Cohort Study. Clin Infect Dis. 2025 Apr 30; 80(4):893-900.
-
Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination. JAMA Netw Open. 2025 Apr 01; 8(4):e252841.
-
Association of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination and Reductions in Post COVID Conditions Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in a US Prospective Cohort of Essential Workers. J Infect Dis. 2025 Mar 17; 231(3):665-676.
-
rVSV?G-ZEBOV-GP Vaccine Is Highly Immunogenic and Efficacious Across a Wide Dose Range in a Nonhuman Primate EBOV Challenge Model. Viruses. 2025 Feb 28; 17(3).
-
Effectiveness of the Original Monovalent Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination Series Against Hospitalization for COVID-19-Associated Venous Thromboembolism. J Infect Dis. 2025 Feb 20; 231(2):378-385.
-
Structural mapping of polyclonal IgG responses to HA after influenza virus vaccination or infection. mBio. 2025 Mar 12; 16(3):e0203024.
-
Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season. J Infect Dis. 2025 Feb 04; 231(1):e123-e131.
-
COVID-19 Vaccination and Odds of Post-COVID-19 Condition Symptoms in Children Aged 5 to 17 Years. JAMA Netw Open. 2025 Feb 03; 8(2):e2459672.
-
COVID-19 and influenza vaccine Hesitancy among adults hospitalized in the United States, 2019-2022. Vaccine. 2025 Feb 27; 48:126806.